Marksans Pharma Ltd to acquire ABCnow GmbH

Marksans Pharma Limited has entered into a definitive agreement to acquire 100% of the share capital of ABCnow GmbH, a Germany based pharmaceutical company with frontend sales, marketing, and distribution capabilities across German healthcare market.

The acquisition marks a strategic step in expanding Marksans' presence across regulated European markets and strengthening its forward-integration strategy through direct, owned market-access capabilities in the European Union.

This acquisition will enable Marksans to use the front-end sales and marketing infrastructure of ABCnow GmbH for marketing its products manufactured in India, UK, and USA regions. It will bolster Marksans' presence in the European markets.

ABCnow GmbH is a pharmaceutical wholesale and distribution company headquartered in Flensburg, Germany. It is primarily engaged in marketing & distribution of OTC products in Germany.

ABCnow presents an attractive opportunity to gain access to German pharma markets and with its capable and well-trained team of professionals can support Marksans' growth aspirations. With this acquisition, Marksans will create its own front end in Germany to market its products.

It was incorporated in the year 2023 and it achieved revenue of € 510,215.60 in 2024 and € 227,233.69 in 2025.

Shares of Marksans Pharma Limited was last trading in BSE at Rs. 272.35 as compared to the previous close of Rs. 276.85. The total number of shares traded during the day was 161804 in over 2625 trades.

The stock hit an intraday high of Rs. 281.00 and intraday low of 270.10. The net turnover during the day was Rs. 44365624.00.

Source : Equity Bulls

Keywords

MarksansPharma INE750C01026 Pharmaceuticals Acquisition ABCnowGmbH